Literature DB >> 22883163

Factors associated with the epidemic of hospitalizations due to atrial fibrillation.

Christopher X Wong1, Anthony G Brooks, Dennis H Lau, Darryl P Leong, Michelle T Sun, Thomas Sullivan, Kurt C Roberts-Thomson, Prashanthan Sanders.   

Abstract

Recent reports have described that hospitalizations for atrial fibrillation (AF) are continuing to increase. Given that hospitalizations are responsible for most of the economic burden associated with AF, the aim of this study was to characterize the impact of age and how changing procedural practices may be contributing to the increasing rates of AF hospitalizations. The annual age- and gender-specific incidence of hospitalizations for AF, electrical cardioversions, electrophysiologic studies, and radiofrequency ablation procedures in Australia were determined from 1993 to 2007 inclusive. Over this 15-year follow-up period spanning almost 300 million person-years, a total of 473,501 hospitalizations for AF were identified. There was a relative increase in AF hospitalizations of 203% over the study period, in contrast to an increase for all hospitalizations of only 71%. Whereas the gender-specific incidence of hospitalizations remained stable, the age-specific incidence increased significantly over the study period, particularly in older age groups. AF hospitalizations associated with electrical cardioversions decreased from 27% to 14% over the study period. Electrophysiologic studies and radiofrequency ablation procedures contributed minimally to the overall increase in AF hospitalizations observed. In conclusion, in addition to the growing prevalence of AF because of the aging population, there is an increasing age-specific incidence of hospitalizations for AF, particularly in older age groups. In contrast, changing procedural trends have contributed minimally to the increasing number of AF-associated hospitalizations. Greater attention to older patients with AF is required to develop strategies to prevent hospitalizations and contain the growing burden on health care systems.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22883163     DOI: 10.1016/j.amjcard.2012.07.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  The Role of Pericardial and Epicardial Fat in Atrial Fibrillation Pathophysiology and Ablation Outcomes.

Authors:  Christopher X Wong; Rajiv Mahajan; Rajeev Pathak; Darragh J Twomey; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2013-02-12

Review 2.  Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.

Authors:  Rajeev Pathak; Dennis H Lau; Rajiv Mahajan; Prashanthan Sanders
Journal:  J Atr Fibrillation       Date:  2013-12-31

Review 3.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

4.  Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment.

Authors:  Peter Ghijben; Emily Lancsar; Silva Zavarsek
Journal:  Pharmacoeconomics       Date:  2014-11       Impact factor: 4.981

5.  Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study.

Authors:  Christopher X Wong; Anthony G Brooks; Yi-Han Cheng; Dennis H Lau; Geetanjali Rangnekar; Kurt C Roberts-Thomson; Jonathan M Kalman; Alex Brown; Prashanthan Sanders
Journal:  BMJ Open       Date:  2014-10-24       Impact factor: 2.692

6.  Association of sex, age and education level with patient reported outcomes in atrial fibrillation.

Authors:  Kelly T Gleason; Cheryl R Dennison Himmelfarb; Daniel E Ford; Harold Lehmann; Laura Samuel; Hae Ra Han; Sandeep K Jain; Gerald V Naccarelli; Vikas Aggarwal; Saman Nazarian
Journal:  BMC Cardiovasc Disord       Date:  2019-04-05       Impact factor: 2.298

7.  Coordinating Health Care With Artificial Intelligence-Supported Technology for Patients With Atrial Fibrillation: Protocol for a Randomized Controlled Trial.

Authors:  Liliana Laranjo; Tim Shaw; Ritu Trivedi; Stuart Thomas; Emma Charlston; Harry Klimis; Aravinda Thiagalingam; Saurabh Kumar; Timothy C Tan; Tu N Nguyen; Simone Marschner; Clara Chow
Journal:  JMIR Res Protoc       Date:  2022-04-13

8.  Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure.

Authors:  Jin Ma; Chunxia Yin; Shiyu Ma; Huiliang Qiu; Chaoyang Zheng; Qiuxiong Chen; Chunhua Ding; Weihui Lv
Journal:  Drug Des Devel Ther       Date:  2018-10-10       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.